Donor marrow progenitors (CFU-Mix, BFU-E and CFU-GM) and haemopoietic engraftment following HLA matched sibling bone marrow transplantation.

[1]  A. Faille,et al.  Granulocyte progenitor compartments after allogeneic bone marrow grafts. , 2009, Scandinavian journal of haematology.

[2]  B. Petersen.  Constant post-irradiation repopulation rates and linear relationship between cellular blood response and number of transplanted bone marrow cells in inbred mice. , 2009, Scandinavian journal of haematology.

[3]  E. Lemarié,et al.  Recovery of CFU-GM from cryopreserved marrow and in vivo evaluation after autologous bone marrow transplantation are predictive of engraftment. , 1986, Experimental hematology.

[4]  R. Gale,et al.  The early complications of bone marrow transplantation. , 1984, Seminars in hematology.

[5]  A. Hoffbrand,et al.  Differential cytotoxicity of deoxyguanosine and 8‐aminoguanosine for human leukemic cell lines and normal bone marrow progenitor cells , 1984, Hematological oncology.

[6]  D. Neville,et al.  EX-VIVO TREATMENT OF DONOR BONE MARROW WITH ANTI-T-CELL IMMUNOTOXINS FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE , 1984, The Lancet.

[7]  G. Janossy,et al.  DEPLETION OF T LYMPHOCYTES IN DONOR MARROW PREVENTS SIGNIFICANT GRAFT-VERSUS-HOST DISEASE IN MATCHED ALLOGENEIC LEUKAEMIC MARROW TRANSPLANT RECIPIENTS , 1984, The Lancet.

[8]  J. Biggs,et al.  Bone marrow transplantation in 33 patients with malignant blood diseases and severe aplastic anaemia , 1983, The Medical journal of Australia.

[9]  J. Biggs,et al.  Cyclosporin A is associated with faster engraftment and less mucositis than methotrexate after allogeneic bone marrow transplantation , 1983, British journal of haematology.

[10]  E. Gordon-Smith,et al.  Regeneration of peripheral blood cells following allogeneic bone marrow transplantation for severe aplastic anaemia , 1982, British journal of haematology.

[11]  R. Bast,et al.  AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN CALLA-POSITIVE ACUTE LYMPHOBLASTIC LEUKAEMIA AFTER IN-VITRO TREATMENT WITH J5 MONOCLONAL ANTIBODY AND COMPLEMENT , 1982, The Lancet.

[12]  D. Ma,et al.  Comparison of two methods for concentrating stem cells for cryopreservation and transplantation , 1982, Transfusion.

[13]  W. Friedrich,et al.  T-lymphocyte reconstitution in recipients of bone marrow transplants with and without GVHD: imbalances of T-cell subpopulations having unique regulatory and cognitive functions. , 1982, Blood.

[14]  D. Ma,et al.  Factors influencing myeloid stem cell (CFU-C) survival after cryopreservation of human marrow and chronic granulocytic leukemia cells. , 1982, Cryobiology.

[15]  B. Netzel,et al.  Fractionated total body irradiation and autologous bone marrow transplantation in dogs: hemopoietic recovery after various marrow cell doses. , 1980, Experimental hematology.

[16]  A. Zander,et al.  The myeloid progenitor cell--its value in predicting hematopoietic recovery after autologous bone marrow transplantation. , 1980, Blood.

[17]  R. Storb,et al.  Marrow transplantation for treatment of aplastic anaemia. , 1978, Clinics in haematology.

[18]  R. Storb,et al.  Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection. , 1977, The New England journal of medicine.